Insight

Consensus Recommendations from IASLC on neoadjuvant and adjuvant treatment for NSCLC

IASLC/X

Jun 26, 2024, 06:12

Consensus Recommendations from IASLC on neoadjuvant and adjuvant treatment for NSCLC

Rami Manochakian shared a post on X:

“Hot off the press!

Just published in JTO and JTO CRR.

Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC) on:

Neoadjuvant and adjuvant treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC).”

IASLC

Additional information.
Source: Rami Manochakian/X

Dr. Rami Manochakian is a thoracic medical oncologist at Mayo Clinic, Florida. He obtained his medical degree from the University of Aleppo in Syria before completing his Internal Medicine residency and chief residency at the University at Buffalo, NY. Dr. Manochakian further honed his expertise through a Hematology/Oncology fellowship and served as chief fellow at Case Western Reserve University, Cleveland, OH. Specializing in thoracic malignancies, including lung cancer, mesothelioma, and thymic tumors, he has dedicated his career to advancing the field of oncology.

Dr. Manochakian’s commitment to patient care extends beyond treatment, as he actively participates in clinical research to drive advancements in oncology. He is also recognized as a leader in medical education, serving in various educational and advisory roles at Mayo Clinic and national and international medical societies, including ASCO, ALA, and IASLC. Dr. Manochakian’s passion for education has earned him numerous awards and achievements, reflecting his dedication to training the next generation of oncologists. Through his tireless efforts, Dr. Manochakian continues to make significant contributions to cancer care, education, and research.